Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Unknown 3Completed 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 9Leukemia 9Lymphoma 6Leukemia, Monocytic, Acute 4Prostatic Neoplasms 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelomonocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Biphenotypic, Acute 2Breast Neoplasms 2Recurrence 1Neutropenia 1Myelodysplastic Syndromes 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hodgkin Disease 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Tretinoin 11Arsenic Trioxide 7Idarubicin 4Mitoxantrone 3Etoposide 3Daunorubicin 3Cytarabine 3Thioguanine 2Radiotherapy 2Cyclophosphamide 2sargramostim 1Watchful Waiting 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Mercaptopurine 1Hydroxyurea 1Filgrastim 1Busulfan 1Bortezomib 1Ascorbic Acid 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Leukemia, Promyelocytic, Acute × Mitoxantrone × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00002701 2013-09-20

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00180128 2011-07-11

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Technische Universität Dresden

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡